Literature DB >> 11599959

2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex.

B Spingler1, D A Whittington, S J Lippard.   

Abstract

(1R,2R-Diaminocyclohexane)oxalatoplatinum(II) (oxaliplatin) is a third-generation platinum anticancer compound that produces the same type of inter- and intrastrand DNA cross-links as cisplatin. In combination with 5-fluorouracil, oxaliplatin has been recently approved in Europe, Asia, and Latin America for the treatment of metastatic colorectal cancer. We present here the crystal structure of an oxaliplatin adduct of a DNA dodecanucleotide duplex having the same sequence as that previously reported for cisplatin (Takahara, P. M.; Rosenzweig, A. C.; Frederick, C. A.; Lippard, S. J. Nature 1995, 377, 649-652). Pt-MAD data were used to solve this first X-ray structure of a platinated DNA duplex derived from an active platinum anticancer drug other than cisplatin. The overall geometry and crystal packing of the complex, refined to 2.4 A resolution, are similar to those of the cisplatin structure, despite the fact that the two molecules crystallize in different space groups. The platinum atom of the [Pt(R,R-DACH)](2+) moiety forms a 1,2-intrastrand cross-link between two adjacent guanosine residues in the sequence 5'-d(CCTCTGGTCTCC), bending the double helix by approximately 30 degrees toward the major groove. Both end-to-end and end-to-groove packing interactions occur in the crystal lattice. The latter is positioned in the minor groove opposite the platinum cross-link. A novel feature of the present structure is the presence of a hydrogen bond between the pseudoequatorial NH hydrogen atom of the (R,R)-DACH ligand and the O6 atom of the 3'-G of the platinated d(GpG) lesion. This finding provides structural evidence for the importance of chirality in mediating the interaction between oxaliplatin and duplex DNA, calibrating previously published models used to explain the reactivity of enantiomerically pure vicinal diamine platinum complexes with DNA in solution. It also provides a new kind of chiral recognition between an enantiomerically pure metal complex and the DNA double helix.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11599959     DOI: 10.1021/ic010790t

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  39 in total

1.  Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.

Authors:  C L King; S Ramachandran; S G Chaney; L Collins; J A Swenberg; K E DeKrafft; W Lin; L Cicurel; M Barbier
Journal:  Cancer Chemother Pharmacol       Date:  2011-10-04       Impact factor: 3.333

2.  Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy.

Authors:  Abhimanyu Paraskar; Shivani Soni; Bhaskar Roy; Anne-Laure Papa; Shiladitya Sengupta
Journal:  Nanotechnology       Date:  2012-02-24       Impact factor: 3.874

3.  Pt-bridges in various single-strand and double-helix DNA sequences. DFT and MP2 study of the cisplatin coordination with guanine, adenine, and cytosine.

Authors:  Matej Pavelka; Jaroslav V Burda
Journal:  J Mol Model       Date:  2006-09-20       Impact factor: 1.810

4.  Bifunctional binding of cisplatin to DNA: why does cisplatin form 1,2-intrastrand cross-links with ag but not with GA?

Authors:  Yogita Mantri; Stephen J Lippard; Mu-Hyun Baik
Journal:  J Am Chem Soc       Date:  2007-04-03       Impact factor: 15.419

5.  Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog.

Authors:  Jaroslav Malina; Olga Novakova; Marie Vojtiskova; Giovanni Natile; Viktor Brabec
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

Review 6.  Synthetic methods for the preparation of platinum anticancer complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Chem Rev       Date:  2013-11-27       Impact factor: 60.622

7.  Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Inorg Chem       Date:  2011-03-01       Impact factor: 5.165

8.  Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting.

Authors:  Katherine S Lovejoy; Stephen J Lippard
Journal:  Dalton Trans       Date:  2009-10-01       Impact factor: 4.390

9.  catena-Poly[cadmium(II)-μ-benzene-1,2-diamine-κN:N'-di-μ-chlorido].

Authors:  Wen-Xian Liang; Zhi-Rong Qu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-09-06

10.  Differences in conformational dynamics of [Pt3(HPTAB)]6+-DNA adducts with various cross-linking modes.

Authors:  Yanyan Zhu; Yan Wang; Guangju Chen
Journal:  Nucleic Acids Res       Date:  2009-08-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.